000661 长春高新
交易中 07-15 13:26:54
资讯
新帖
简况
道通科技目标价涨幅超65%,长春高新评级被调低丨券商评级观察
21世纪经济报道 · 07-14 00:49
道通科技目标价涨幅超65%,长春高新评级被调低丨券商评级观察
长春高新:公司管理层高度重视市值管理工作
证券之星 · 07-11
长春高新:公司管理层高度重视市值管理工作
7月7日深成500下跌0.23%,板块个股盈峰环境、长春高新跌幅居前
金融界 · 07-07
7月7日深成500下跌0.23%,板块个股盈峰环境、长春高新跌幅居前
7月7日深成500概念下跌0.23%,板块个股盈峰环境、长春高新跌幅居前
金融界 · 07-07
7月7日深成500概念下跌0.23%,板块个股盈峰环境、长春高新跌幅居前
7月7日长春高新跌5.62%,招商国证生物医药指数(LOF)C基金重仓该股
证券之星 · 07-07
7月7日长春高新跌5.62%,招商国证生物医药指数(LOF)C基金重仓该股
长春高新:痛风属于代谢性疾病但从产品布局属自免领域
证券之星 · 07-04
长春高新:痛风属于代谢性疾病但从产品布局属自免领域
长春高新:2024年度相关股息已到账
证券之星 · 07-04
长春高新:2024年度相关股息已到账
7月3日长春高新(000661)龙虎榜数据:机构净卖出645.15万元,北向资金净买入1.33亿元
证券之星 · 07-03
7月3日长春高新(000661)龙虎榜数据:机构净卖出645.15万元,北向资金净买入1.33亿元
长春高新涨10.00%,中国银河二个月前给出“买入”评级
证券之星 · 07-03
长春高新涨10.00%,中国银河二个月前给出“买入”评级
7月3日长春高新(000661)涨停分析:高分红兑现、百元股溢价、创新药突破驱动
证券之星 · 07-03
7月3日长春高新(000661)涨停分析:高分红兑现、百元股溢价、创新药突破驱动
异动快报:长春高新(000661)7月3日13点0分触及涨停板
证券之星 · 07-03
异动快报:长春高新(000661)7月3日13点0分触及涨停板
龙头药企再传重磅,国内首只药ETF(562050)拉涨1%!神州细胞飙升18%,长春高新涨超7%
市场资讯 · 07-03
龙头药企再传重磅,国内首只药ETF(562050)拉涨1%!神州细胞飙升18%,长春高新涨超7%
医药生物企业赴港IPO热度持续升温 长春高新启动H股上市筹备
证券 · 07-02
医药生物企业赴港IPO热度持续升温 长春高新启动H股上市筹备
长春高新:加快新产品研发及引进力度
证券之星 · 06-27
长春高新:加快新产品研发及引进力度
长春高新:公司子公司百克生物正在开展预防生殖器疱疹临床试验
证券之星 · 06-27
长春高新:公司子公司百克生物正在开展预防生殖器疱疹临床试验
长春高新收盘下跌1.01%,滚动市盈率18.38倍,总市值403.86亿元
金融界 · 06-20
长春高新收盘下跌1.01%,滚动市盈率18.38倍,总市值403.86亿元
长春高新:公司相关产品效率及效益情况符合医药行业产品研发及销售规律
证券之星 · 06-14
长春高新:公司相关产品效率及效益情况符合医药行业产品研发及销售规律
长春高新:目前剩余的垫付款项对应部分地块
证券之星 · 06-14
长春高新:目前剩余的垫付款项对应部分地块
长春高新:公司不掌握相关情况,董秘称
问董秘 · 06-14
长春高新:公司不掌握相关情况,董秘称
长春高新最新公告:子公司金赛药业GenSci134注射液临床试验申请获得批准
证券之星 · 06-13
长春高新最新公告:子公司金赛药业GenSci134注射液临床试验申请获得批准
加载更多
公司概况
公司名称:
长春高新技术产业(集团)股份有限公司
所属行业:
医药制造业
上市日期:
1996-12-18
主营业务:
长春高新技术产业(集团)股份有限公司的主营业务是生物制药及中成药的研发、生产和销售,辅以房地产开发等业务。公司的主要产品是注射用人生长激素、重组人生长激素注射液、聚乙二醇重组人生长激素注射液、营养保健产品、体重控制产品、电子注射笔、骨龄及生长发育检测设备、赛优姿系列产品、盐酸托莫西汀胶囊、注射用重组人促卵泡激素、醋酸曲普瑞林注射液、利丙双卡因乳膏、醋酸甲地孕酮口服混悬液、口腔凝胶。
发行价格:
8.80
{"stockData":{"symbol":"000661","market":"SZ","secType":"STK","nameCN":"长春高新","latestPrice":98.88,"timestamp":1752557214000,"preClose":100.67,"halted":0,"volume":5358803,"delay":0,"changeRate":-0.0178,"floatShares":400000000,"shares":408000000,"eps":5.3858,"marketStatus":"交易中","change":-1.79,"latestTime":"07-15 13:26:54","open":101.02,"high":101.1,"low":98.6,"amount":533000000,"amplitude":0.0248,"askPrice":98.95,"askSize":1,"bidPrice":98.89,"bidSize":2,"shortable":0,"etf":0,"ttmEps":5.3858,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1752562800000},"marketStatusCode":2,"adr":0,"adjPreClose":100.67,"symbolType":"stock","openAndCloseTimeList":[[1752543000000,1752550200000],[1752555600000,1752562800000]],"highLimit":110.74,"lowLimit":90.6,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":407937529,"isCdr":false,"pbRate":1.75,"roa":"--","peRate":18.35939,"roe":"2.03%","epsLYR":6.42,"committee":0.571429,"marketValue":40337000000,"turnoverRate":0.0134,"status":1,"floatMarketCap":39515000000},"requestUrl":"/m/hq/s/000661","defaultTab":"news","newsList":[{"id":"2551216759","title":"道通科技目标价涨幅超65%,长春高新评级被调低丨券商评级观察","url":"https://stock-news.laohu8.com/highlight/detail?id=2551216759","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551216759?lang=zh_cn&edition=full","pubTime":"2025-07-14 08:49","pubTimestamp":1752454148,"startTime":"0","endTime":"0","summary":"南财投研通数据显示,7月7日至7月11日,券商给予上市公司目标价共88次,按最新收盘价计算,目标价涨幅排名居前的公司有道通科技、万华化学、正帆科技,目标价涨幅分别为68.84%、61.52%、60.11%,分别属于计算机设备、化学制品、专用设备行业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714085140a6a76a04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714085140a6a76a04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688208","000661"],"gpt_icon":0},{"id":"2550793409","title":"长春高新:公司管理层高度重视市值管理工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2550793409","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550793409?lang=zh_cn&edition=full","pubTime":"2025-07-11 18:12","pubTimestamp":1752228741,"startTime":"0","endTime":"0","summary":"证券之星消息,长春高新07月11日在投资者关系平台上答复投资者关心的问题。投资者提问:早两年公司市值是超过药明康德的,而现在公司的市值已经不足药明康德的1/10,请问公司管理层如何看待这一变化?股价可能受到短期基本面、市场情绪、宏观经济、投资者偏好等多重因素影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071100033015.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0075","BK0057","BK0188","BK0046","000661"],"gpt_icon":0},{"id":"2549531838","title":"7月7日深成500下跌0.23%,板块个股盈峰环境、长春高新跌幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2549531838","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549531838?lang=zh_cn&edition=full","pubTime":"2025-07-07 19:20","pubTimestamp":1751887216,"startTime":"0","endTime":"0","summary":"7月7日,截至收盘,深成500概念下跌0.23%,板块资金流出927981.21万。上涨个股家数185个,下跌个股家数304个。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/07192051536063.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0218","BK0028","BK0101","BK0075","BK0239","BK0057","000661","BK0046","000967","BK0188"],"gpt_icon":0},{"id":"2549839531","title":"7月7日深成500概念下跌0.23%,板块个股盈峰环境、长春高新跌幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2549839531","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549839531?lang=zh_cn&edition=full","pubTime":"2025-07-07 19:19","pubTimestamp":1751887196,"startTime":"0","endTime":"0","summary":"7月7日,截至收盘,深成500概念下跌0.23%,板块资金流出927981.21万。上涨个股家数185个,下跌个股家数304个。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/07191951536066.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0218","BK0188","BK0075","BK0239","BK0057","000661","000967","BK0046","BK0028","BK0101"],"gpt_icon":0},{"id":"2549589352","title":"7月7日长春高新跌5.62%,招商国证生物医药指数(LOF)C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2549589352","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549589352?lang=zh_cn&edition=full","pubTime":"2025-07-07 16:24","pubTimestamp":1751876677,"startTime":"0","endTime":"0","summary":"证券之星消息,7月7日长春高新跌5.62%,收盘报100.3元,换手率3.04%,成交量12.13万手,成交额12.44亿元。根据2025基金Q1季报公募基金重仓股数据,重仓该股的公募基金共76家,其中持有数量最多的公募基金为招商基金的招商国证生物医药指数C。招商国证生物医药指数C目前规模为18.39亿元,最新净值0.3921,较上一交易日上涨0.54%,近一年上涨15.49%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070700020856.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0075","000661","BK0046","BK0188","399441","BK0057","161726","BK0028"],"gpt_icon":0},{"id":"2548366095","title":"长春高新:痛风属于代谢性疾病但从产品布局属自免领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2548366095","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548366095?lang=zh_cn&edition=full","pubTime":"2025-07-04 16:45","pubTimestamp":1751618723,"startTime":"0","endTime":"0","summary":"证券之星消息,长春高新(000661)07月04日在投资者关系平台上答复投资者关心的问题。投资者提问:我记得金磊在研发日说过,痛风是代谢性疾病,昨晚公司公告却说:本产品获批有利于丰富公司成人自免领域的产品布局,痛风到底是自免疾病还是代谢类疾病长春高新回复:您好,从医学角度痛风属于代谢性疾病,从产品应用场景及公司内部业务管线方面属于自免领域,谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070400026151.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","BK0046","000661","BK0075","BK0057","BK0239"],"gpt_icon":0},{"id":"2548365339","title":"长春高新:2024年度相关股息已到账","url":"https://stock-news.laohu8.com/highlight/detail?id=2548365339","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548365339?lang=zh_cn&edition=full","pubTime":"2025-07-04 16:21","pubTimestamp":1751617286,"startTime":"0","endTime":"0","summary":"证券之星消息,长春高新(000661)07月04日在投资者关系平台上答复投资者关心的问题。投资者提问:25年没有股息分配了吗长春高新回复:您好,2024年度相关股息已到账,对于2025年度其他报告期,如有相关安排,公司会按照法律法规要求履行审议披露程序,谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070400025426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0075","BK0057","000661","BK0028","BK0188","BK0239","BK0046"],"gpt_icon":0},{"id":"2548051872","title":"7月3日长春高新(000661)龙虎榜数据:机构净卖出645.15万元,北向资金净买入1.33亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548051872","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548051872?lang=zh_cn&edition=full","pubTime":"2025-07-03 17:15","pubTimestamp":1751534132,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2025年7月3日公布的交易公开信息显示,长春高新因日涨幅偏离值达到7%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年7月3日收盘,长春高新报收于108.69元,上涨10.0%,涨停,换手率4.06%,成交量16.24万手,成交额17.23亿元。从龙虎榜公布的当日买卖数据来看,机构合计净卖出645.15万元,北向资金合计净买入1.33亿元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070300027843.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000661","BK0028","BK0188","BK0075","BK0046","BK0239","BK0057"],"gpt_icon":0},{"id":"2548587984","title":"长春高新涨10.00%,中国银河二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2548587984","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548587984?lang=zh_cn&edition=full","pubTime":"2025-07-03 16:28","pubTimestamp":1751531308,"startTime":"0","endTime":"0","summary":"今日长春高新涨10.00%,收盘报108.69元。2025年4月22日,中国银河研究员程培,宋丽莹发布了对长春高新的研报《2024年报及2025年一季报点评:费用率提升致利润承压,创新转型进行中》,该研报对长春高新给出“买入”评级。研报中预计公司2025-2027年分别实现归母净利润30、33、37亿元,对应PE分别为13、11、10倍,维持“推荐”评级。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为35.34%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070300026158.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000661","601881"],"gpt_icon":0},{"id":"2548878017","title":"7月3日长春高新(000661)涨停分析:高分红兑现、百元股溢价、创新药突破驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2548878017","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548878017?lang=zh_cn&edition=full","pubTime":"2025-07-03 15:25","pubTimestamp":1751527558,"startTime":"0","endTime":"0","summary":"证券之星消息,长春高新7月3日涨停收盘,收盘价108.69元。该股于13点0分涨停,未打开涨停,截止收盘封单资金为1.27亿元,占其流通市值0.29%。7月3日的资金流向数据方面,主力资金净流入2.16亿元,占总成交额12.52%,游资资金净流出1.18亿元,占总成交额6.83%,散户资金净流出9794.67万元,占总成交额5.69%。近5日资金流向一览见下表:该股为创新药,阿尔茨海默病,疫苗概念热股,当日创新药概念上涨2.66%,阿尔茨海默病概念上涨2.6%,疫苗概念上涨2.05%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070300019613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000661","BK0028","BK0188","BK0075","BK0046","BK0239","159992","BK0057","06978","BK1161","BK1574"],"gpt_icon":0},{"id":"2548821599","title":"异动快报:长春高新(000661)7月3日13点0分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2548821599","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548821599?lang=zh_cn&edition=full","pubTime":"2025-07-03 13:05","pubTimestamp":1751519127,"startTime":"0","endTime":"0","summary":"证券之星7月3日盘中消息,13点0分长春高新触及涨停板。目前价格108.69,上涨10.0%。其所属行业生物制品目前上涨。领涨股为神州细胞。该股为阿尔茨海默病,创新药,疫苗概念热股,当日阿尔茨海默病概念上涨2.2%,创新药概念上涨1.93%,疫苗概念上涨1.86%。7月3日的资金流向数据方面,主力资金净流入4684.68万元,占总成交额3.45%,游资资金净流出1669.72万元,占总成交额1.23%,散户资金净流出3014.96万元,占总成交额2.22%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070300018148.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000661","BK0188","BK0057","BK0075","BK0046","BK0239","BK0028"],"gpt_icon":0},{"id":"2548828521","title":"龙头药企再传重磅,国内首只药ETF(562050)拉涨1%!神州细胞飙升18%,长春高新涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548828521","media":"市场资讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548828521?lang=zh_cn&edition=full","pubTime":"2025-07-03 10:20","pubTimestamp":1751509200,"startTime":"0","endTime":"0","summary":"7月3日早盘,制药板块再度活跃,聚焦龙头药企的药ETF拉升逾1%。成份股方面,创新药概念股再度领涨,神州细胞飙升逾18%,长春高新涨超7%。此外,中药龙头以岭药业同步大涨近6%。 公开资料显示,药ETF是国内首只跟踪中证制药指数的ETF,纯粹配置“化学药+生物药品+中药”三大领域龙头制药企业,不含医疗和CXO。聚焦制药板块机会,认准国内首只药ETF,既有创新药驱动高成长,又有中药降低指数波动,并且完全不含医疗和CXO。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2025-07-03/doc-infeeerq1729933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0046","000661","BK0188","562050","BK0028","BK0075","688520","BK0057"],"gpt_icon":0},{"id":"2548818260","title":"医药生物企业赴港IPO热度持续升温 长春高新启动H股上市筹备","url":"https://stock-news.laohu8.com/highlight/detail?id=2548818260","media":"证券","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548818260?lang=zh_cn&edition=full","pubTime":"2025-07-02 21:11","pubTimestamp":1751461860,"startTime":"0","endTime":"0","summary":"目前,长春高新已按合规流程确定并启动与相关中介机构的沟通与合作,公司正在与相关中介机构就本次H股上市的具体推进工作进行商讨。医药生物企业“扎堆”赴港IPO今年以来,A股公司赴港上市热度持续攀升,“A+H”队伍不断壮大,年内已有7家A股公司成功赴港上市。分行业来看,医药生物企业“扎堆”赴港IPO。截至目前,有6家医药生物企业成功登陆港股,已超去年全年总量。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-07-02/doc-infeawwf4276011.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000661","BK0239","BK0057","163118","BK0028","BK0075","BK0046","000808.SH","BK0188"],"gpt_icon":0},{"id":"2546714666","title":"长春高新:加快新产品研发及引进力度","url":"https://stock-news.laohu8.com/highlight/detail?id=2546714666","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546714666?lang=zh_cn&edition=full","pubTime":"2025-06-27 17:57","pubTimestamp":1751018229,"startTime":"0","endTime":"0","summary":"证券之星消息,长春高新06月27日在投资者关系平台上答复投资者关心的问题。因此公司去年结合实际业务情况,相应增加了人员。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062700030192.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000661","BK0028","BK0075","BK0239","BK0057","BK0188","BK0046"],"gpt_icon":0},{"id":"2546148777","title":"长春高新:公司子公司百克生物正在开展预防生殖器疱疹临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2546148777","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546148777?lang=zh_cn&edition=full","pubTime":"2025-06-27 17:54","pubTimestamp":1751018050,"startTime":"0","endTime":"0","summary":"投资者提问:1.请问感染带状疱疹的能接种贵公司的疱疹疫苗吗?对于单纯疱疹方面,公司子公司百克生物正在开展预防由II型单纯疱疹病毒感染导致的生殖器疱疹的临床试验,谢谢!","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062700029805.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03347","BK0057","BK0188","BK1583","BK1576","BK0239","688276","BK0046","000661","BK1141","BK0028","BK0075"],"gpt_icon":0},{"id":"2544114628","title":"长春高新收盘下跌1.01%,滚动市盈率18.38倍,总市值403.86亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544114628","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544114628?lang=zh_cn&edition=full","pubTime":"2025-06-20 16:11","pubTimestamp":1750407112,"startTime":"0","endTime":"0","summary":"6月20日,长春高新今日收盘99.0元,下跌1.01%,滚动市盈率PE达到18.38倍,总市值403.86亿元。从行业市盈率排名来看,公司所处的生物制品行业市盈率平均60.79倍,行业中值41.52倍,长春高新排名第31位。截至2025年一季报,共有87家机构持仓长春高新,其中基金84家、其他3家,合计持股数13493.65万股,持股市值131.97亿元。最新一期业绩显示,2025年一季报,公司实现营业收入29.97亿元,同比-5.66%;净利润4.73亿元,同比-44.95%,销售毛利率88.22%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/20161151198400.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0057","BK0239","BK0046","BK0028","000661","BK0075","BK0188"],"gpt_icon":0},{"id":"2543650862","title":"长春高新:公司相关产品效率及效益情况符合医药行业产品研发及销售规律","url":"https://stock-news.laohu8.com/highlight/detail?id=2543650862","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543650862?lang=zh_cn&edition=full","pubTime":"2025-06-14 12:54","pubTimestamp":1749876849,"startTime":"0","endTime":"0","summary":"证券之星消息,长春高新06月14日在投资者关系平台上答复投资者关心的问题。投资者提问:哈哈,看到了贵公司5月30日对尾号147提问的回答有点说不出的味道。公司长篇大论,讲了一堆前面已经重复过多次的空话。长春高新回复:您好,公司是在最近几年快速提升研发投入,目前已有多项包括1类新药在内的创新产品进入上市申请或临床阶段,药品研发具有周期长的特点,公司相关产品效率及效益情况符合医药行业产品研发及销售规律。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061400012493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000661","BK0239","BK0188","BK0046","BK0075","BK0028","BK0057"],"gpt_icon":0},{"id":"2543577166","title":"长春高新:目前剩余的垫付款项对应部分地块","url":"https://stock-news.laohu8.com/highlight/detail?id=2543577166","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543577166?lang=zh_cn&edition=full","pubTime":"2025-06-14 12:48","pubTimestamp":1749876489,"startTime":"0","endTime":"0","summary":"证券之星消息,长春高新(000661)06月14日在投资者关系平台上答复投资者关心的问题。投资者提问:公司前期垫付的十几亿拆迁款是包含了康达地块56万平方米的所有地块吗长春高新回复:您好,目前剩余的垫付款项对应部分地块,整个康达旧改项目中一些已经摘牌的地块已经开发为海容广场、高新容园等项目,此前垫付的部分款项已经返还,谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061400012345.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000661","BK0028","BK0057","BK0046","BK0188","BK0075"],"gpt_icon":0},{"id":"2543365721","title":"长春高新:公司不掌握相关情况,董秘称","url":"https://stock-news.laohu8.com/highlight/detail?id=2543365721","media":"问董秘","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543365721?lang=zh_cn&edition=full","pubTime":"2025-06-14 12:41","pubTimestamp":1749876060,"startTime":"0","endTime":"0","summary":"投资者提问:请问,公司那个券商的券源比较多,要融券,融不到!董秘回答(长春高新SZ000661):您好,公司不掌握相关情况。谢谢!查看更多董秘问答>>免责声明:本信息由新浪财经从公开信息中摘录,不构成任何投资建议;新浪财经不保证数据的准确性,内容仅供参考。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/dongmiqa/2025-06-14/doc-inezzfqn5611898.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0188","BK0057","BK0239","BK0046","000661","BK0028","BK0075"],"gpt_icon":0},{"id":"2543689001","title":"长春高新最新公告:子公司金赛药业GenSci134注射液临床试验申请获得批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2543689001","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543689001?lang=zh_cn&edition=full","pubTime":"2025-06-13 19:29","pubTimestamp":1749814192,"startTime":"0","endTime":"0","summary":"长春高新(000661.SZ)公告称,公司子公司金赛药业收到国家药品监督管理局核准签发的《药物临床试验批准通知书》,金赛药业GenSci134注射液的境内生产药品注册临床试验申请获得批准。GenSci134注射液是金赛药业自主研发的一款治疗用生物制品1类药物,拟用于成人生长激素缺乏症(AGHD)治疗。同日公告,金赛药业收到国家药品监督管理局核准签发的《药物临床试验批准通知书》,授权经销合作产品醋酸甲地孕酮口服混悬液(美适亚®)的境外生产药品注册临床试验申请获得批准。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061300034518.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0188","000661","BK0075","BK0057","BK0046","BK1141","BK1583","03347","BK1576"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1752557217763,"stockEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":-0.0678},{"period":"3month","weight":0.0722},{"period":"6month","weight":0.0957},{"period":"1year","weight":0.1113},{"period":"ytd","weight":0.0368}],"compareEarnings":[{"period":"1week","weight":0.0134},{"period":"1month","weight":0.0422},{"period":"3month","weight":0.0771},{"period":"6month","weight":0.0906},{"period":"1year","weight":0.1846},{"period":"ytd","weight":0.0501}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"长春高新技术产业(集团)股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"125097人(较上一季度减少1.80%)","perCapita":"3194股","listingDate":"1996-12-18","address":"吉林省长春市朝阳区高新区海容酒店及海茵广场写字楼B座2708室","registeredCapital":"40793万元","survey":" 长春高新技术产业(集团)股份有限公司的主营业务是生物制药及中成药的研发、生产和销售,辅以房地产开发等业务。公司的主要产品是注射用人生长激素、重组人生长激素注射液、聚乙二醇重组人生长激素注射液、营养保健产品、体重控制产品、电子注射笔、骨龄及生长发育检测设备、赛优姿系列产品、盐酸托莫西汀胶囊、注射用重组人促卵泡激素、醋酸曲普瑞林注射液、利丙双卡因乳膏、醋酸甲地孕酮口服混悬液、口腔凝胶。","listedPrice":8.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"长春高新(000661)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供长春高新(000661)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"长春高新,000661,长春高新股票,长春高新股票老虎,长春高新股票老虎国际,长春高新行情,长春高新股票行情,长春高新股价,长春高新股市,长春高新股票价格,长春高新股票交易,长春高新股票购买,长春高新股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"长春高新(000661)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供长春高新(000661)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}